Mesothelioma Cancer & Lung Disease » Mesothelioma Clinical Studies http://www.mesotheliomalungs.org up-to-date news on asbestos related disease Sat, 04 Feb 2012 15:17:35 +0000 en hourly 1 http://wordpress.org/?v=3.1.3 Prof Vogl, Scientific Proposal, Transarterial Thoracic Chemoperfusion. http://www.mesotheliomalungs.org/prof-vogl-chemoembolisation-clinical-sudy-mesothelioma http://www.mesotheliomalungs.org/prof-vogl-chemoembolisation-clinical-sudy-mesothelioma#comments Thu, 15 Apr 2010 11:01:55 +0000 Ann-Marie Waters http://www.mesotheliomalungs.org/?p=881 Recent clinical study of chemoembolisation treatment – carried out by Professor Thomas Vogl on patients suffering from pleural mesothelioma. (copy of official documents).

Professor Thomas. J. vogl carried out a 5 year clinical study in the use of ‘Regional Thoracic Chemoperfusion (TACP)’ in the palliative treatment of’ Malignant Pleural Mesothelioma’. He has treated many mesothelioma patients from the UK as the treatment is only currently available in Germany – where Professor Vogl’s clinic is based.

Professor Vogl and his colleagues have recently published the results of the clinical study and put forward the proposal for evaluation.

 

Please find attached proposed evaluation of the study titled: “Regional Transarterial thoracic chemoperfusion (TACP) in the palliative treatment of recurrent Malignant Pleural mesothelioma -  here

 

Professor T. Vogl MD.

 

Professor Volgl – Credentials:

  • Graduated from Ludwig Maximilian University Munich with M.D. in 1982 Residency in Radiology, University of Munic
  • German Board of Radiology 1987
  • Assistant Professor, University of Munich 1988
  • Associate and Full Professor of the Free University of Berlin 1992
  • Professor of Humboldt University of Berlin 1995
  • Senior Faculty Diagnostic Radiologist, Virchow Clinic 1991-1997
  • Chairman Department of Radiology university of Frankfurt, Department of Diagnostic and Interventional Radiology

     

    ]]> http://www.mesotheliomalungs.org/prof-vogl-chemoembolisation-clinical-sudy-mesothelioma/feed 7